Over 30–35% of patients suffering from acute myeloid leukemia express mutations of FLT3-ITD and FLT3-TKD, consequently resulting in the prolonged activation of proteins that promote cell proliferation and survival [134]. This evidence concerns the gene FLT3 and acute myeloid leukemia.